$2975 | SAVE $525 | Single User
$5950 | SAVE $1,050 | Site License
$8925 | SAVE $1,575 | Enterprise License

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016
[Published by Global Markets Direct]

Published by Global Markets Direct: 26 Oct 2016 | 20636 | In Stock

Introduction

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016

Summary

Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted pipeline therapeutics.

The report provides comprehensive information on the Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted therapeutics development and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note:

*Certain sections in the report may be removed or altered based on the availability and relevance of data.

*Updated report will be delivered in 48 hours of order confirmation.

Scope

- The report provides a snapshot of the global therapeutic landscape for Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2)

- The report reviews Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources

- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

- The report reviews key players involved in Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted therapeutics and enlists all their major and minor projects

- The report assesses Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type

- The report summarizes all the dormant and discontinued pipeline projects

- The report reviews latest news and deals related to Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand the targeted therapy areas and indications for Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2)

- Identify the use of drugs for target identification and drug repurposing

- Identify potential new clients or partners in the target demographic

- Develop strategic initiatives by understanding the focus areas of leading companies

- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

- Devise corrective measures for pipeline projects by understanding Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) development landscape

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
for Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016 [Published by Global Markets Direct]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 4

    Introduction 5

    Global Markets Direct Report Coverage 5

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) Overview 6

    Therapeutics Development 7

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Products under Development by Stage of Development 7

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Products under Development by Therapy Area 8

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Products under Development by Indication 9

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Products Glance 10

    Late Stage Products 10

    Early Stage Products 11

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Products under Development by Companies 12

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Products under Development by Universities/Institutes 14

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Therapeutics Assessment 16

    Assessment by Monotherapy/Combination Products 16

    Assessment by Mechanism of Action 17

    Assessment by Route of Administration 19

    Assessment by Molecule Type 21

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Companies Involved in Therapeutics Development 22

    Amgen Inc. 22

    Ascendis Pharma A/S 23

    Ono Pharmaceutical Co., Ltd. 24

    Sanofi 25

    Santen Pharmaceutical Co., Ltd. 26

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drug Profiles 27

    omidenepag isopropyl - Drug Profile 27

    Product Description 27

    Mechanism Of Action 27

    R&D Progress 27

    ONO-8055 - Drug Profile 28

    Product Description 28

    Mechanism Of Action 28

    R&D Progress 28

    SAR-366234 - Drug Profile 29

    Product Description 29

    Mechanism Of Action 29

    R&D Progress 29

    Small Molecule to Antagonize EP2 Receptor for Alzheimer's Disease - Drug Profile 30

    Product Description 30

    Mechanism Of Action 30

    R&D Progress 30

    Small Molecules to Antagonize Prostanoid EP2 and EP4 Receptors for Endometriosis - Drug Profile 31

    Product Description 31

    Mechanism Of Action 31

    R&D Progress 31

    TG-4155 - Drug Profile 32

    Product Description 32

    Mechanism Of Action 32

    R&D Progress 32

    treprostinil - Drug Profile 33

    Product Description 33

    Mechanism Of Action 33

    R&D Progress 33

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Dormant Projects 34

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Discontinued Products 35

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Featured News & Press Releases 36

    Apr 28, 2015: Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil 36

    Jan 14, 2015: Ascendis Pharma Announces Initiation of a Phase 1 Single Ascending Dose Study of TransCon Treprostinil 36

    Appendix 37

    Methodology 37

    Coverage 37

    Secondary Research 37

    Primary Research 37

    Expert Panel Validation 37

    Contact Us 37

    Disclaimer 38

Additional Details

Publisher

Global Markets Direct

Publisher Information

Reference

20636 | GMDHC0611TDB

Number of Pages

38

Report Format

PDF

Global Markets Direct Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! DP1 Receptor (Prostaglandin D2 receptor) Antagonists -Pipeline Insights, 2017
DelveInsight’s, “DP1 Receptor (Prostaglandin D2 receptor) Antagonists-Pipeline Insights, 2017”, repo...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostacyclin (Prostaglandin I2) Receptor Agonists -Pipeline Insights, 2017
DelveInsight’s, “Prostacyclin (Prostaglandin I2) Receptor Agonists-Pipeline Insights, 2017”, report ...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin Antagonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin Antagonists-Pipeline Insights, 2017”, report provides in depth insigh...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Agonists-...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin E Receptor 1 (EP1 or Prostaglandin E1 Receptor EP1 Subtype) Antagonis...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin E Receptor 2 (EP2 or Prostaglandin E2 Receptor EP2 Subtype) Agonists-...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin E2 (PGE2) Receptor Antagonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin E2 (PGE2) Receptor Antagonists-Pipeline Insights, 2017”, report provi...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin F2-Alpha Receptor (PGF receptor or Prostanoid FP Receptor) Antagonist...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights, 2017
DelveInsight’s, “Prostaglandin F2-Alpha Receptor Agonists-Pipeline Insights, 2017”, report provides ...
30 May 2017 by Delve Insight USD $1,063 (normally
USD $1,251)
More Info
SAVE 15% today! Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2016
Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or ...
26 Oct 2016 by Global Markets Direct USD $2,975 (normally
USD $3,500)
More Info

This report is published by Global Markets Direct

Download Free Report Summary PDF

Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016 [Published by Global Markets Direct] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...